PAPER Heutink P, Jansen IE, Lynes EM
SEARCH RESULTS
330988 RESULTS
PAPER Sim YJ
Treadmill exercise alleviates impairment of spatial learning ability through enhancing cell proliferation in the streptozotocin-induced Alzheimer's disease rats.
J Exerc Rehabil. 2014 Apr;10(2):81-8. Epub 2014 Apr 30 PubMed: 24877042PAPER Wolfe MS
Targeting mRNA for Alzheimer's and related dementias.
Scientifica (Cairo). 2014;2014:757549. Epub 2014 Apr 27 PubMed: 24876993PAPER Chen KC, Liu YC, Lee CC, Chen CY
Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.
Evid Based Complement Alternat Med. 2014;2014:278493. Epub 2014 Apr 30 PubMed: 24876869PAPER
Erratum: Profile of gantenerumab and its potential in the treatment of Alzheimer's disease [Corrigendum].
Drug Des Devel Ther. 2014;8 Epub 2014 May 21 PubMed: 24876767PAPER Ford AH
Neuropsychiatric symptoms of dementia: are pharmacological treatments effective and safe?
J Neurol Neurosurg Psychiatry. 2014 May 29; PubMed: 24876187PAPER Wang J, Yu JT, Wang HF, Meng XF, Wang C, Tan CC, Tan L
Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis.
J Neurol Neurosurg Psychiatry. 2014 May 29; PubMed: 24876182PAPER Condic M, Oberstein TJ, Herrmann M, Reimann MC, Kornhuber J, Maler JM, Spitzer P
N-truncation and pyroglutaminylation enhances the opsonizing capacity of Aβ-peptides and facilitates phagocytosis by macrophages and microglia.
Brain Behav Immun. 2014 Oct;41:116-25. Epub 2014 May 27 PubMed: 24876064PAPER Zeb A, Hameed A, Khan L, Khan I, Dalvandi K, Choudhary MI, Basha FZ
Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Med Chem. 2014;10(7):724-9. PubMed: 24875826PAPER Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S
Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland.
J Clin Psychopharmacol. 2014 Aug;34(4):435-40. PubMed: 24875073PAPER Rivera-Escalera F, Matousek SB, Ghosh S, Olschowka JA, O'Banion MK
Interleukin-1β mediated amyloid plaque clearance is independent of CCR2 signaling in the APP/PS1 mouse model of Alzheimer's disease.
Neurobiol Dis. 2014 Sep;69:124-33. Epub 2014 May 27 PubMed: 24874542PAPER Burbaeva GS, Boksha IS, Tereshkina EB, Starodubtseva LI, Savushkina OK, Vorob'eva EA, Prokhorova TA
[A role of glutamate decarboxylase in Alzheimer's disease].
Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(4):68-72. PubMed: 24874321PAPER Marwarha G, Raza S, Meiers C, Ghribi O
Leptin attenuates BACE1 expression and amyloid-β genesis via the activation of SIRT1 signaling pathway.
Biochim Biophys Acta. 2014 Sep;1842(9):1587-95. Epub 2014 May 27 PubMed: 24874077PAPER Tariot PN
When should neuroprotective drugs move from mice to men?
Lancet Neurol. 2014 Jul;13(7):641-3. Epub 2014 May 27 PubMed: 24873721PAPER Stolley JM
Reaching Communities with Alzheimer's Education: Advanced Train-The-Trainer Manual.
J Gerontol Nurs. 2002 Jun 1;28(6):51. PubMed: 24869399Current Filters
No filters selected